Atlas Trials

Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment

Clinical trial NCT05883761 · COMPLETED

Trial details

NCT number
NCT05883761
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Status
COMPLETED
Study type
OBSERVATIONAL
Neural Tube DefectsCongenital AbnormalitiesTeratogens
Start date
2021-09-07
Primary completion
2023-09-30
Enrollment
50075

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.